¼¼°èÀÇ ÈäºÎ Ä«Å×ÅÍ ½ÃÀå
Thoracic Catheters
»óǰÄÚµå : 1793890
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 374 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License)
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)


Çѱ۸ñÂ÷

ÈäºÎ Ä«Å×ÅÍ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 7¾ï 3,200¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 5¾ï 740¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ÈäºÎ Ä«Å×ÅÍ ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 6.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7¾ï 3,200¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Ä«Å×ÅÍ´Â CAGR 7.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 5¾ï 4,150¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾×¼¼¼­¸® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 3,820¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÈäºÎ Ä«Å×ÅÍ ½ÃÀåÀº 2024³â¿¡ 1¾ï 3,820¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 10.1%·Î 2030³â±îÁö 1¾ï 5,170¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.0%¿Í 6.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÈäºÎ Ä«Å×ÅÍ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÈäºÎ Ä«Å×ÅÍ´Â ÁßȯÀÚ Ä¡·á ÀÌÈÄ¿¡µµ °íÁ¤¹Ð µµ±¸·Î ÁøÈ­ÇÒ °ÍÀΰ¡?

ÈäºÎ Ä«Å×ÅÍ´Â ÀϹÝÀûÀ¸·Î Èä°üÀ̶ó°í ºÒ¸®´Â ÈäºÎ Ä«Å×ÅÍ´Â È丷°­À̳ª Á¾°Ýµ¿¿¡¼­ °ø±â, ¾×ü, °í¸§ ¶Ç´Â Ç÷¾×À» ¹èÃâÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ÀÇ·á Àåºñ·Î, ÀϹÝÀûÀ¸·Î ¿Ü»ó, ¼ö¼ú ¶Ç´Â ½É°¢ÇÑ Æó Áúȯ ÈÄ¿¡ »ç¿ëµË´Ï´Ù. ÀüÅëÀûÀ¸·Î ÀÀ±Þ½Ç, ÁßȯÀÚ½Ç, ¼ö¼ú ÈÄ È¯°æ¿¡ ¹èÄ¡µÇ¾î ¿Ô´ø ÀÌ ÀåºñµéÀº ÇöÀç µðÀÚÀÎ °³¼±°ú ½Ã¼ú Ç¥ÁØÈ­ÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖÀ¸¸ç, °í±Þ ÈäºÎ ¹× Æó Ä¡·áÀÇ ÇÙ½É ±¸¼º¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ±× ¿ëµµ´Â ±âÁ¸ÀÇ °³Èä¼ú¿¡¼­ ¿µ»ó À¯µµ »ðÀÔ¼ú, ºñµð¿À º¸Á¶ Èä°­°æ ¼ö¼ú(VATS)°ú °°Àº ÃÖ¼Òħ½ÀÀû ½Ã¼ú·Î È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ÁßȯÀÚ Ä¡·á¿¡¼­ Á¤¹Ð ÁÖµµÇü °³ÀÔÀ¸·ÎÀÇ ±¤¹üÀ§ÇÑ º¯È­¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.

ÈäºÎ Ä«Å×ÅÍÀÇ Á߿伺Àº ¸¸¼º ÆóÁúȯ, ÈäºÎ ¾Ç¼º Á¾¾ç, ¿Ü»ó ¹× ½ÉÈäºÎ ¼ö¼ú·Î ÀÎÇÑ ÇÕº´Áõ ¹ß»ý·üÀÇ Áõ°¡¿Í ÇÔ²² Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±âÈä ¹× Ç÷Èä °ü¸®ÀÇ ¿ªÇÒ ¿Ü¿¡µµ, ÀÌ Ä«Å×ÅÍ´Â ¿ïÇ÷¼º ½ÉºÎÀü, °¨¿°, ¾Ç¼º Á¾¾ç°ú °ü·ÃµÈ Èä¼ö ¹èÃâ¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÇ·áÁøÀÌ ÈäºÎ ÀÀ±Þ»óȲ¿¡ ´ëÇÑ Á¶±â °³ÀÔ°ú ½Å¼ÓÇÑ °¨¾ÐÀ» ¿ì¼±½ÃÇÔ¿¡ µû¶ó Èä°­ Ä«Å×ÅÍ ½Ã½ºÅÛÀº ¹è¾×»Ó¸¸ ¾Æ´Ï¶ó ½Ç½Ã°£ ¸ð´ÏÅ͸µ, Á¦¾îµÈ ÈíÀÔ, Àå±âÀûÀΠȯÀÚÀÇ Æí¾ÈÇÔÀ» Áö¿øÇϵµ·Ï Á¶Á¤µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁøÈ­¸¦ ÅëÇØ Ä«Å×ÅÍ´Â Áúº´ °ü¸® °æ·Î¿¡¼­ »çÈÄÀû µµ±¸¿¡¼­ »çÀü ¿¹¹æÀû ÀåÄ¡·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

Ä«Å×ÅÍ µðÀÚÀΰú ºÎ¼Ó ½Ã½ºÅÛÀº ¾î¶»°Ô ȯÀÚ Áß½ÉÀ¸·Î º¯È­Çϰí Àִ°¡?

ÃÖ±Ù ÈäºÎ Ä«Å×ÅÍ ¼³°èÀÇ ±â¼ú Çõ½ÅÀº ½Ã¼ú·Î ÀÎÇÑ ¿Ü»ó °¨¼Ò, ¹è¾× È¿À² Çâ»ó, ȯÀÚ À̵¿¼º Çâ»ó¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. »õ·Î¿î Ä«Å×Åʹ ȯÀÚÀÇ ÇØºÎÇÐÀû ±¸Á¶¿¡ ´õ Àß ¸Â°í Á¶Á÷ ¼Õ»óÀÇ À§ÇèÀ» ÁÙÀ̸ç, ´õ ºÎµå·´°í º¯»öµÇÁö ¾Ê´Â ½Ç¸®ÄÜ ¶Ç´Â Æú¸®¿ì·¹Åº ¼ÒÀç·Î Á¦°øµË´Ï´Ù. ƯÈ÷ ¿Ü·¡ ȯÀÚ³ª Àå±â°£ ¹è¾×ÀÌ ÇÊ¿äÇÑ °æ¿ì, º¸´Ù ÃÖ¼Òħ½ÀÀûÀÌ°í Æí¾ÈÇÑ »ðÀÔÀÌ °¡´ÉÇÑ ÇDZ×Å×ÀÏÇü Ä«Å×ÅͰ¡ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Æ®·ÎÄ¿°¡ ÇÊ¿ä ¾ø´Â »ðÀÔ¼ú°ú ¼¿µù°Å ŰƮ¸¦ ÅëÇØ °æÇÇÀû »ðÀÔÀÌ °¡´ÉÇÏ¿© ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­ÇÏ°í ½Ã¼úÀÇ Á¤È®µµ¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÈäºÎ Ä«Å×ÅÍ¿Í Ã·´Ü ¹è¾× ½Ã½ºÅÛ°úÀÇ ÅëÇÕµµ È®´ëµÇ¾ú½À´Ï´Ù. µðÁöÅÐ Èä°­ ¹è¾× ½Ã½ºÅÛÀº ±â·ù, ºÎÇÇ, ¾Ð·ÂÀÇ ¿¬¼ÓÀûÀÎ ½Ç½Ã°£ ÃøÁ¤ÀÌ °¡´ÉÇÏ¿© ÀÓ»óÀÇ¿¡°Ô ÀÇ»ç°áÁ¤ ¹× ÇÕº´Áõ Á¶±â ¹ß°ßÀ» À§ÇÑ ½Ç¿ëÀûÀÎ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¿ª·ù ¹æÁö ¹ëºê¿Í ÈíÀÔ ¿É¼ÇÀÌ ÅëÇÕµÈ ¹ÐÆóÇü ÈÞ´ë¿ë ¹è¼ö ÀåÄ¡´Â °¨¿° À§ÇèÀ» ÁÙÀ̰í ȸº¹±â ȯÀÚÀÇ À̵¿¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀçÅÃÀÇ·á ¹× ¿ÏÈ­ ÀÇ·á ÇöÀå¿¡¼­´Â ÀÌ·¯ÇÑ ¹ßÀüÀÌ ÃÖ¼ÒÇÑÀÇ °¨½Ã ÇÏ¿¡ Èä°­ ¹è¾×¼úÀ» ½ÃÇàÇÏ´Â ¹æÇâÀ¸·ÎÀÇ ÀüȯÀ» Áö¿øÇÏ¿© ÀÔ¿ø ±â°£À» ´ÜÃàÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ±Þ¼º±â ÀÇ·á¿Í ¸¸¼º±â ÀÇ·áÀÇ ´ÏÁî¿¡ ºÎÇÕÇϴ ȯÀÚ Ä£È­ÀûÀ̰í À§ÇèÀÌ ÀûÀº Ä«Å×ÅÍ ½Ã½ºÅÛÀ¸·Î ½ÃÀåÀÌ À̵¿Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

½Ã¼ú Ç¥ÁØÈ­¿Í ÀÓ»ó ±³À°ÀÌ ½ÃÀå ÁøÀÔ °¡´É¼ºÀ» È®´ëÇÒ ¼ö ÀÖÀ»±î?

Èä°­ Ä«Å×ÅÍÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â Áß¿äÇÑ ¿ä¼Ò´Â Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄÝÀÇ È®¸³°ú ÀÓ»ó ÈÆ·ÃÀÇ °³¼±ÀÔ´Ï´Ù. ÇöÀå Áø·á ÃÊÀ½ÆÄ(POCUS)ÀÇ »ç¿ëÀÌ ÈäºÎ Æò°¡ÀÇ Ç¥ÁØÀ¸·Î ÀÚ¸® ÀâÀ¸¸é¼­, ƯÈ÷ ÀÀ±Þ ÀÇ·á ¹× Áö¹æ ÀÇ·á ȯ°æ¿¡¼­ À¯µµ Ä«Å×ÅÍ »ðÀÔÀ» ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î ½ÃÇàÇÒ ¼ö ÀÖ´Â ´É·ÂÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ½Ã¹Ä·¹ÀÌ¼Ç ±â¹Ý ±³À°°ú ¸ð¹ü »ç·Ê °¡À̵å¶óÀÎÀ» ÅëÇØ ÈäºÎ¿Ü°ú Àǻ糪 È£Èí±â Àü¹®Àǰ¡ ¾Æ´Ñ ÀÇ·áÁøµµ ´Ù¾çÇÑ Á¶°Ç¿¡¼­ ¾ÈÀüÇÏ°Ô Ä«Å×Å͸¦ »ðÀÔÇÒ ¼ö ÀÖ´Â ±â¼úÀ» ½ÀµæÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, Á¾¾ç³»°ú, ÀÀ±ÞÀÇÇаú, ÀÀ±ÞÀÇÇаú, ÀÀ±Þ±¸Á¶Çаú, ¿ÏÈ­ÀÇÇаú µî °¢ ÆÀÀÌ Àü¹® ºÐ¾ß¸¦ ³Ñ¾î Çù·ÂÇÔÀ¸·Î½á ´ÙÇÐÁ¦Àû Ä¡·á °èȹ¿¡¼­ ÈäºÎ Ä«Å×ÅÍÀÇ Æø³ÐÀº »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Áø·áºñ Áö¿ø, ½Ã¼úÀÇ Àϰý ÄÚµù, ±ÔÁ¦ ¸íȮȭ, ƯÈ÷ °øÁߺ¸°Ç ½Ã½ºÅÛ ¹× °³¹ßµµ»ó±¹¿¡¼­ÀÇ Á¢±Ù¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦µµÀû º¯È­·Î ÀÎÇØ ±Þ¼º±â ÀÇ·á¿Í ¿Ü·¡ ÀÇ·á ¸ðµÎ¿¡¼­ ÈäºÎ Ä«Å×ÅÍ Ä¡·á°¡ º¸´Ù ±¤¹üÀ§Çϰí È®½ÇÇÏ°Ô ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ±× °á°ú, »ý¸íÀ» À§ÇùÇÏ´Â »óȲ¿¡¼­ ¼Ò±ØÀûÀ¸·Î Àü°³µÇ´ø Èä°­ ¹è¾× °ü¸®°¡ º¸´Ù Àû±ØÀûÀÎ ÇÁ·ÎÅäÄÝ Áß½ÉÀÇ Èä°­ ¹è¾× °ü¸®·Î ½ÃÀåÀÌ ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

¼¼°è ÈäºÎ Ä«Å×ÅÍ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀº?

ÈäºÎ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ÀÎÇÁ¶óÀÇ È®Àå, ½Ã¼úÀÇ Çõ½Å, Áúº´ ºÎ´ãÀÇ ¿ªµ¿¼º°ú ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµË´Ï´Ù. ù°, ÈäºÎ ¿Ü»ó, Æó °¨¿°, COPD, ¼ö¼ú ÈÄ ÇÕº´Áõ Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÎ ¹è¾× ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ²ÙÁØÈ÷ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µÑ°, ´õ ºÎµå·¯¿î ¼ÒÀç, ´õ ÀÛÀº ±¸°æÀÇ ±¸¼º, ´õ ¾ÈÀüÇÑ Å°Æ® µî Ä«Å×ÅÍ ¼³°èÀÇ ¹ßÀüÀ¸·Î ħ½ÀÀû ¹× ºñħ½ÀÀû ȯ°æ¿¡¼­ Ä«Å×ÅÍÀÇ ÀÓ»ó Àû¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¼Â°, ÈäºÎ Ä«Å×ÅÍ¿Í Æó¼â ·çÇÁ µðÁöÅÐ ¹è¾× ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀº ƯÈ÷ ÁýÁß Ä¡·á ¹× ¼ö¼ú ÈÄ È¸º¹±âÀÇ ¸ð´ÏÅ͸µ Á¤È®µµ¿Í ȯÀÚ °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù. ³Ý°, ÃÖ¼Òħ½ÀÀû ÈäºÎ ½Ã¼ú°ú ¿µ»ó À¯µµ¸¦ ÅëÇÑ Ä«Å×ÅÍ »ðÀÔÀ¸·ÎÀÇ ÀüȯÀº ¿Ü·¡ ¹× µ¥ÀÌÄÉ¾î ¼ö¼ú ¼¾ÅÍ¿¡¼­ÀÇ »ç¿ëÀ» È®´ëÇÏ¿© ÀÔ¿ø ±â°£°ú ºñ¿ëÀ» Àý°¨Çϰí ÀÖ½À´Ï´Ù. ´Ù¼¸Â°, ¸¸¼º È丷 Áúȯ¿¡ ´ëÇÑ ÀçÅÃÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ Àå±â°£ »ç¿ëÇÒ ¼ö ÀÖ´Â »ç¿ëÇϱ⠽¬¿î ÈÞ´ë¿ë Èä°­ ¹è¾× ½Ã½ºÅÛÀÇ °³¹ßÀÌ Àå·ÁµÇ°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, ÀÀ±ÞÀÇ·á ¿ª·®ÀÌ È®´ëµÇ°í ÀÖ´Â ½ÅÈï ½ÃÀå¿¡¼­´Â ±³À° Á¢±Ù¼º, ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø, Ç¥ÁØÈ­µÈ ÀÓ»ó ÇÁ·ÎÅäÄÝÀÌ º¸±ÞÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ä¼ÒµéÀ» Á¾ÇÕÇϸé, ÈäºÎ Ä«Å×ÅÍ´Â ±Þ¼º ¹× ¸¸¼º ÆóÁúȯ Ä¡·á¿¡ ÇʼöÀûÀÎ ÁøÈ­ÇÏ´Â µµ±¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(Ä«Å×ÅÍ, ¾×¼¼¼­¸®), ¿ëµµ(Èä¼ö, ±âÈä, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø, ASC, Àü¹® Ŭ¸®´Ð)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Thoracic Catheters Market to Reach US$732.0 Million by 2030

The global market for Thoracic Catheters estimated at US$507.4 Million in the year 2024, is expected to reach US$732.0 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Catheters, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$541.5 Million by the end of the analysis period. Growth in the Accessories segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$138.2 Million While China is Forecast to Grow at 10.1% CAGR

The Thoracic Catheters market in the U.S. is estimated at US$138.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$151.7 Million by the year 2030 trailing a CAGR of 10.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Thoracic Catheters Market - Key Trends & Drivers Summarized

Are Thoracic Catheters Evolving Into Precision Tools for Critical Care and Beyond?

Thoracic catheters-commonly referred to as chest tubes-are essential medical devices used to drain air, fluid, pus, or blood from the pleural space or mediastinum, typically after trauma, surgery, or severe pulmonary disease. Traditionally deployed in emergency departments, intensive care units, and post-operative settings, these devices are now benefiting from design enhancements and procedural standardization, positioning them as core components in advanced thoracic and pulmonary care. Their usage has expanded from conventional open thoracostomy procedures to include minimally invasive techniques such as image-guided insertions and video-assisted thoracoscopic surgery (VATS), reflecting a broader shift toward precision-driven interventions in critical care.

The importance of thoracic catheters has grown alongside the rising incidence of chronic lung diseases, thoracic malignancies, traumatic injuries, and complications from cardiothoracic surgeries. In addition to their role in managing pneumothorax and hemothorax, these catheters are now integral in draining pleural effusions related to congestive heart failure, infections, and malignancies. As healthcare providers prioritize early intervention and rapid decompression in thoracic emergencies, thoracic catheter systems are being adapted to support not only drainage but also real-time monitoring, controlled suction, and long-term patient comfort. This evolution is shifting catheters from being reactive tools to proactive devices in disease management pathways.

How Are Catheter Designs and Accessory Systems Becoming More Patient-Centric?

Recent innovations in thoracic catheter design have focused on reducing procedural trauma, improving drainage efficiency, and enhancing patient mobility. Newer catheters are available in softer, kink-resistant silicone or polyurethane materials that conform better to patient anatomy and reduce the risk of tissue damage. Low-profile, pigtail-shaped catheters are gaining popularity for less invasive placements and improved comfort, especially in outpatient settings or when long-term drainage is needed. Furthermore, trocar-free insertion techniques and Seldinger kits allow for percutaneous placement, minimizing complications and improving procedural accuracy.

The integration of thoracic catheters with advanced drainage systems has also expanded. Digital chest drainage systems now enable continuous measurement of airflow, volume, and pressure in real time, providing clinicians with actionable insights for decision-making and early detection of complications. Closed, portable drainage units with anti-reflux valves and integrated suction options are reducing infection risk and allowing greater patient mobility during recovery. In home healthcare and palliative settings, these advances are supporting the shift toward minimally supervised thoracic drainage-improving quality of life while reducing hospital stays. These trends demonstrate the market's pivot toward patient-friendly, low-risk catheter systems that align with both acute and chronic care needs.

Can Procedural Standardization and Clinical Training Widen Market Accessibility?

A critical component driving thoracic catheter adoption is the establishment of standardized protocols and improved clinical training. As the use of point-of-care ultrasound (POCUS) becomes standard for thoracic assessments, the ability to perform guided catheter insertions safely and effectively has increased, particularly in emergency and rural healthcare environments. Simulation-based training and best-practice guidelines are equipping medical personnel-beyond thoracic surgeons and pulmonologists-with the skills to safely perform catheter insertions under various conditions.

In addition, cross-specialty collaboration between oncology, emergency medicine, critical care, and palliative care teams is fostering broader use of thoracic catheters in multidisciplinary treatment plans. Reimbursement support, bundled procedure coding, and regulatory clarity are also enhancing accessibility, particularly in public health systems and developing regions. These systemic changes are enabling more widespread, confident use of thoracic catheterization in both high-acuity and outpatient settings. The result is a market shift from reactive deployment in life-threatening scenarios to more proactive, protocol-driven thoracic drainage management.

What Is Fueling the Expansion of the Thoracic Catheters Market Globally?

The growth in the thoracic catheters market is driven by several factors closely aligned with healthcare infrastructure expansion, procedural innovation, and disease burden dynamics. First, the increasing prevalence of thoracic trauma, lung infections, COPD, and post-surgical complications is driving steady demand for effective drainage solutions. Second, advancements in catheter design-including softer materials, small-bore configurations, and safety-enhanced kits-are broadening clinical adoption in both invasive and non-invasive settings.

Third, the integration of thoracic catheters with closed-loop, digital drainage systems is improving monitoring accuracy and patient outcomes, especially in intensive care and postoperative recovery. Fourth, the shift toward minimally invasive thoracic procedures and image-guided catheter placements is expanding use in outpatient and day-care surgery centers, reducing hospitalization times and costs. Fifth, the growing focus on home-based care for chronic pleural conditions is encouraging development of user-friendly, portable thoracic drainage systems for long-term use. Lastly, increased training accessibility, regulatory support, and standardized clinical protocols are driving penetration in emerging markets with expanding emergency care capacity. These factors collectively position thoracic catheters as indispensable, evolving tools in the continuum of acute and chronic pulmonary care.

SCOPE OF STUDY:

The report analyzes the Thoracic Catheters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Catheters, Accessories); Application (Pleural Effusion Application, Pneumothorax Application, Other Applications); End-Use (Hospitals End-Use, ASCs End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â